Siblings Books/Book Section [4/5] Conference Papers/Meeting Abstract [3/4] Patents [0/44] Collection Statistics Item counts issued in 3 years:2(2.00%) Items With Fulltext:97(97.00%) Download counts of the item Download times greater than 0:97(100.00%) Download times greater than 100:97(100.00%) Total Bitstream Download Counts:66935(94.67%) Last Update: 2024-11-28 06:48 Top Upload Loading... Top Download Loading... Recent Submissions Propagation and immunological chara... The uncoating of EV71 in mature lat... Polysorbasome: A colloidal vesicle ... Enhancing enterovirus A71 vaccine p... Degradable emulsion as vaccine adju... Development of a full-length cDNA-d... Immunogenicity of a novel tetravale... Mucosal delivery of a combination a... Immunological and biochemical chara... The successful induction of T-cell ...

Jump to a point in the index: (Choose year) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-25 of 100. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page

Date	Title	Relation
2023-03-24	Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system	Virus Research. 2023 Mar 24;329:Article number 199101.
2022-09-15	The uncoating of EV71 in mature late endosomes requires CD-M6PR	Biology Open. 2022 Sep 15;11(9):Article number bio059469.
2018-05	Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture	Vaccine. 2018 May;36(22):3134-3139.
2018-04-18	Polysorbasome: A colloidal vesicle contoured by polymeric bioresorbable amphiphiles as an immunogenic depot for vaccine delivery	ACS Applied Materials and Interfaces. 2018 Apr 18;10(15):12553-12561.
2016-11-09	Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy	Scientific Reports. 2016 Nov 09;6:Article number 36732.
2016-11	Mucosal delivery of a combination adjuvant comprising emulsified fine particles and LD-indolicidin enhances serological immunity to inactivated influenza virus	Microbes and Infection. 2016 Nov;18(11):706-709.
2016-08	Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology	Antiviral Research. 2016 Aug;132:225-232.
2016-07-29	Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice	Scientific Reports. 2016 Jul 29;6:Article number 30648.
2016-07	The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection	Human Vaccines and Immunotherapeutics. 2016 Jul;12(7):1678-1689.
2016-05	Immunological and biochemical characterizations of Coxsackievirus A6 and A10 viral particles	Antiviral Research. 2016 May;129:58-66.
2016-02	Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice	Vaccine. 2016 Feb;34(8):1054-1061.
2015-12-29	The immunodominance change and protection of CD4+ T-cell responses elicited by an envelope protein domain III-based tetravalent dengue vaccine in mice	PLoS ONE. 2015 Dec 29;10(12):Article number e0145717.
2015-12	Recombinant bacterial lipoproteins as vaccine candidates	Expert Review of Vaccines. 2015 Dec;14(12):1623-1632.
2015-12	Depletion of regulatory T-cells leads to moderate B-cell antigenicity in respiratory syncytial virus infection	International Journal of Infectious Diseases. 2015 Dec;41:56-64.
2015-11	Is a multivalent hand, foot, and mouth disease vaccine feasible?	Human Vaccines and Immunotherapeutics. 2015 Nov;11(11):2688-2704.
2015-08-13	Biochemical and immunological characterization of truncated fragments of the receptor-binding domains of C. difficile toxin A	PLoS ONE. 2015 Aug 13;10(8):Article number e0135045.
2015-08-07	Recombinant lipoprotein-based vaccine candidates against C. difficile infections	Journal of Biomedical Science. 2015 Aug 7;22:Article number 65.
2015-06	Recombinant lipoproteins as novel vaccines with intrinsic adjuvant	Advances in Protein Chemistry and Structural Biology. 2015 Jun;99:55-74.
2015-04	Recombinant adeno-vaccine expressing Enterovirus 71-like particles against hand, foot, and mouth disease	PLoS Neglected Tropical Diseases. 2015 Apr;9(4):Article number e0003692.
2015-03	Review of enterovirus 71 vaccines	Clinical Infectious Diseases. 2015 Mar;60(5):797-803.
	Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology	Human Vaccines and Immunotherapeutics. 2015 Apr;11(4):1065-1073.
2014-11	Depletion of tumor-associated macrophages enhances the anti-tumor immunity induced by a toll-like receptor agonist-conjugated peptide	Human Vaccines and Immunotherapeutics. 2014 Nov;10(11):3241-3250.
2014-10	Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases	Vaccine. 2014 Oct;32(47):6177-6182.
2014-09-08	Long-term immunogenicity studies of formalin-inactivated Enterovirus 71 whole-virion vaccine in macaques	PLoS ONE. 2014 Sep 8;9(9):Article number e106756.
2014-09	A poorly neutralizing IgG2a/c response elicited by a DNA vaccine protects mice against Japanese encephalitis virus	Journal of General Virology. 2014 Sep;95(Pt 9):1983-1990.

Showing items 1-25 of 100. (4 Page(s) Totally) 1 2 3 4 > >> View [10|25|50] records per page